FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:591-593 August 22, 1996 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Just as the study of rare inborn errors of metabolism has yielded important insights into normal metabolic pathways, the study of rare genetic defects can help define the roles of cellular morphogens and their receptors. The recent demonstration of mutations of fibroblast growth factor receptors in patients with several inherited forms of craniosynostosis is an example.¹ In this issue of the Journal, Shafritz et al.² describe the overexpression of a bone morphogenetic protein in patients with the rare inherited form of ectopic ossification known as fibrodysplasia ossificans progressiva. They suggest that their findings can provide insight into the normal biology . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.